MIR4742

Across TCGA pan-cancer cohorts, MIR4742 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated MIR4742 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher MIR4742 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4742 expression acts as an unfavorable survival marker, although some lineages such as LIHC and ESCA show a favorable association.

THCA, SKCM, and ACC are the cancer types where MIR4742 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.861	0.969	<.001	90	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	57	view →
ACC	OS	Tertile	All	0.548	0.920	<.001	45	view →
COAD	DFS	Tertile	IV	0.245	0.520	.001	45	view →
LIHC	OS	Tertile	II,III,IV	0.966	0.701	.016	24	view →
LUSC	DFS	Median	IV	0.134	0.827	.014	20	view →
ESCA	DFS	Quartile	All	1.000	0.436	.024	15	view →
TGCT	OS	Tertile	All	0.927	0.992	.030	12	view →
MESO	OS	Tertile	IV	0.188	0.622	.021	9	view →
CHOL	DFS	Tertile	III,IV	0.133	0.779	.038	6	view →
READ	DFS	Tertile	All	0.238	0.601	.025	6	view →
KICH	OS	Tertile	III,IV	1.000	0.559	.036	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

MIR4742–THCA (OS)

Open the THCA breakdown →